Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome.

Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome.

Item
http://www.wikidata.org/entity/Q42456707
Combined oral contraceptives in the treatment of polycystic ovary syndrome.The effects of old, new and emerging medicines on metabolic aberrations in PCOS.The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies.Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.Determinants of circulating adiponectin in women with polycystic ovary syndrome.Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil/lymphocyte ratio.The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.Comparison of two contraceptive pills containing drospirenone and 20 μg or 30 μg ethinyl estradiol for polycystic ovary syndrome.
P2860

Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome.

Item
http://www.wikidata.org/entity/Q42456707
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Metabolic and endocrine effect ...... ith polycystic ovary syndrome.
@en
Metabolic and endocrine effect ...... ith polycystic ovary syndrome.
@nl
type
label
Metabolic and endocrine effect ...... ith polycystic ovary syndrome.
@en
Metabolic and endocrine effect ...... ith polycystic ovary syndrome.
@nl
prefLabel
Metabolic and endocrine effect ...... ith polycystic ovary syndrome.
@en
Metabolic and endocrine effect ...... ith polycystic ovary syndrome.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Metabolic and endocrine effect ...... with polycystic ovary syndrome
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921